Breakthrough leads to a potential drug for a rare disease for a treatment for primary mitochondrial myopathy
A drug candidate discovered by Peter W. Schiller, Director of the Chemical Biology and Peptide Research unit at the Institut de recherches cliniques de Montréal (IRCM) and Research Professor in the Department of Pharmacology ...
Feb 18, 2016
0
1